| Brittany Pfaff, MOT, OTR/L | |
|
724 24th Ave Nw, Norman, OK 73069-6218 | |
| (405) 447-1571 | |
| Not Available |
| Full Name | Brittany Pfaff |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 724 24th Ave Nw, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346798394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2033 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Pfaff, MOT, OTR/L 724 24th Ave Nw, Norman, OK 73069-6218 Ph: (405) 447-1571 | Brittany Pfaff, MOT, OTR/L 724 24th Ave Nw, Norman, OK 73069-6218 Ph: (405) 447-1571 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
Scientists predict the COVID-19 pandemic is on its way to becoming endemic. The rising spread of COVID-19 variants such as Delta has helped infect unvaccinated and some vaccinated individuals. COVID-19 vaccines continue to be the best way to protect against severe illness and death, but there may be a need for vaccines to protect against a specific variant.
In a study published in Economics & Human Biology researchers from Lehigh University and the University of Wisconsin-Madison found that pregnant women who commute long-distance to work have an increased risk of adverse birth outcomes, including having babies born at a low-birth weight.
A team of University of Georgia faculty members, led by a researcher in the College of Family and Consumer Sciences, has received an $8.2 million grant from the Administration for Children and Families, a division of the U.S. Department of Health and Human Services, to improve the lives of children and families in the child welfare system in Georgia.
Oxygen Biotherapeutics, Inc. ("OBI") a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the protocol of their phase 3 trial for levosimendan has been published on ClinicalTrials.gov, "Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Heart Surgery on Cardiopulmonary Bypass."
› Verified 9 days ago
Ms. Deanna Hewett Elias, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1250 N Interstate Dr, Norman, OK 73072 Phone: 405-573-0121 Fax: 405-573-0124 | |
Ms. Sherryl Marianne Sweeney, OT L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 330 W Gray St, Suite 100-2, Norman, OK 73069 Phone: 405-360-5552 | |
Rachel Shepherd, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2002 E Robinson St, Norman, OK 73071 Phone: 405-307-2800 Fax: 405-307-2801 | |
Amanda Wynn, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-3833 | |
Jessica Klemme, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Lindsey St Ste C-248, Norman, OK 73069 Phone: 405-360-5554 Fax: 405-360-1344 | |
Unlimited Potential Pediatrics Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 24th Ave Nw Ste 100, Norman, OK 73069 Phone: 580-402-3373 | |
Rachel Anne Holland, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Boyd St, Norman, OK 73069 Phone: 405-366-7898 |